Company / Total Assets
Thermo Fisher Scientific Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$110.3B
FY2025
5-year range
$69.1B / $110.3B
FY2021-FY2025
Trend
+13.4%
vs FY2024
Sector context
#5 of 161
Health Care
What the data says
Among 161 Health Care companies, Thermo Fisher Scientific is in the top 3% for total assets. Total Assets has increased for 4 consecutive years, from $69.1B in FY2021 to $110.3B in FY2025.
Based on SEC 10-K filings.
$110.3B in FY2025 with a 5-year CAGR of +9.8%. Top quartile in the Health Care sector.
Improved from $97.2B to $110.3B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +5.1%
- 5-Year CAGR
- +9.8%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 161This company $110.3B Sector average $14.8B
▼
+647.2% above sector average
Key checks
Key Insights
- Thermo Fisher Scientific's total assets has grown for 4 consecutive years.
- 5-year CAGR of +9.8%, indicating consistent growth.
- In FY2025, total assets increased 13.4% year-over-year.
- Ranks #5 out of 161 companies in the Health Care sector.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $110.3B | +13.4% |
| FY2024 | $97.3B | +0.2% |
| FY2023 | $97.2B | +2.1% |
| FY2022 | $95.1B | +37.8% |
| FY2021 | $69.1B | +0.0% |
| FY2020 | $69.1B | +18.3% |
| FY2019 | $58.4B | +3.8% |
| FY2018 | $56.2B | -0.8% |
| FY2017 | $56.7B | +23.4% |
| FY2016 | $45.9B | +12.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026